EHTH
eHealth, Inc.
There isn't enough reported data to score EHTH yet.
GS
The Goldman Sachs Group, Inc.
GS's fundamentals are strong: revenue grew 19% and its operating margin rose 4 points to 40%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
EHTH Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Stable | |
| N/A | |
| N/A |
EHTH's profitability is currently stable, but its revenue is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like EHTH.
GS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
GS's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like GS.
EHTH PE Valuation
EHTH has no meaningful PE right now: it lost money over the past year.
GS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.6x | $528 | -42% |
| Current | 13x | $914 | — |
| Forward | 13x | $914 | — |
| Fair | 14x | $940 | +2.9% |
| Expensive | 17x | $1,214 | +33% |
Historical ranges are pointers, not guarantees.
GS's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
EHTH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Decline | |
| Improving | |
| Limited | |
| High |
Analysts expect EHTH's earnings to grow and its profitability to improve, but its revenue to decline.
GS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
GS has the edge over EHTH on the outlook, with more favorable revenue expectations.
EHTH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.82 | — |
| Q4 2024 | -$1.19 | +$1.18 |
| Q3 2024 | -$2.62 | +$0.78 |
| Q2 2024 | -$2.47 | +$0.97 |
| Q1 2024 | -$2.32 | +$1.59 |
| Q4 2023 | -$2.37 | +$1.99 |
| Q3 2023 | -$3.40 | +$2.89 |
| Q2 2023 | -$3.44 | +$3.37 |
| Q1 2023 | -$3.91 | +$2.11 |
GS has the stronger earnings trend. Trailing diluted EPS is down 150% for EHTH versus GS up 41%.
GS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $72.35 | +4% |
| Q3 2026 | $69.58 | +41% |
| Q2 2026 | $64.82 | +43% |
| Q1 2026 | $54.75 | +27% |
| Q4 2025 | $51.32 | +27% |
| Q3 2025 | $49.22 | +44% |
| Q2 2025 | $45.37 | +45% |
| Q1 2025 | $43.08 | +68% |
| Q4 2024 | $40.54 | +77% |
GS's earnings per share have climbed steadily: $69.58 over the past year, up 41% from the year before, and higher year over year for 10 quarters in a row. Its recent earnings include one-off gains.
EHTH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $21.3M | -60% |
| Q2 2026 | $33.6M | -45% |
| Q1 2026 | $88M | -22% |
| Q4 2025 | $326.2M | +3.5% |
| Q3 2025 | $53.9M | -7.8% |
| Q2 2025 | $60.8M | -7.7% |
| Q1 2025 | $113.1M | +22% |
| Q4 2024 | $315.2M | +27% |
EHTH's revenue is shrinking: $21M last quarter, down 60% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -218% | -141 points |
| Q2 2026 | -82% | -44 points |
| Q1 2026 | -3.3% | -7.5 points |
| Q4 2025 | 39% | +3 points |
| Q3 2025 | -77% | -3.1 points |
| Q2 2025 | -38% | +4.5 points |
| Q1 2025 | 4.2% | +24 points |
| Q4 2024 | 36% | +12 points |
EHTH's operating margin was −218% last quarter, down 141 points from the same quarter a year ago, near the bottom of its range since 2019.
GS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.7B | +23% |
| Q2 2026 | $20.3B | +39% |
| Q1 2026 | $17.2B | +14% |
| Q4 2025 | $13.5B | -3% |
| Q3 2025 | $15.2B | +20% |
| Q2 2025 | $14.6B | +15% |
| Q1 2025 | $15.1B | +6% |
| Q4 2024 | $13.9B | +23% |
GS has the edge over EHTH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 37% | +2 points |
| Q2 2026 | 42% | +8.1 points |
| Q1 2026 | 38% | +0.2 points |
| Q4 2025 | 44% | +5.6 points |
| Q3 2025 | 36% | +4.1 points |
| Q2 2025 | 34% | +3.2 points |
| Q1 2025 | 37% | +0.6 points |
| Q4 2024 | 38% | +18 points |
GS has the edge over EHTH on profitability, with a higher operating margin.
EHTH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$11.3M | +$14.3M |
| Q2 2026 | -$5.4M | +$37.3M |
| Q1 2026 | $35.6M | -54% |
| Q4 2025 | -$36.1M | -$7.8M |
| Q3 2025 | -$25.5M | +$4.8M |
| Q2 2025 | -$42.8M | -$10.3M |
| Q1 2025 | $76.8M | +8.9% |
| Q4 2024 | -$28.3M | +$5.4M |
EHTH's free cash flow was −$17M over the past year, against −$20M the year before. Free cash flow isn't a meaningful measure for financial services companies like EHTH.
GS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +72% |
| Q2 2026 | $5.6B | +7.8% |
| Q1 2026 | -$32.4B | +$5.3B |
| Q4 2025 | -$16.8B | -136% |
| Q3 2025 | $2.1B | +$40.6B |
| Q2 2025 | $5.2B | -6.8% |
| Q1 2025 | -$37.7B | -$9.2B |
| Q4 2024 | $46.2B | +$75.1B |
GS's free cash flow was −$40B over the past year, against $15.8B the year before. Free cash flow isn't a meaningful measure for financial services companies like GS.
EHTH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.1% | +353K shares |
| 1 year | +5.7% | +1.7M shares |
| 3 years | +16% | +4.5M shares |
| 5 years | +21% | +5.5M shares |
| Available history | +31% | +7.6M shares |
EHTH has 32M diluted shares, up 5.7% from a year ago.
GS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -3.8M shares |
| 1 year | -4.4% | -13.9M shares |
| 3 years | -12% | -42.8M shares |
| 5 years | -15% | -52.8M shares |
| Available history | -20% | -74.4M shares |
GS has the edge over EHTH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3B |
| Q2 2026 | $4B |
| Q1 2026 | $5B |
| Q4 2025 | $3B |
| Q3 2025 | $2B |
| Q2 2025 | $3B |
| Q1 2025 | $4.4B |
| Q4 2024 | $2B |
GS spent $15B buying back its own shares over the past year, up 32% from the year before.
EHTH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.1x | Healthy |
| Q2 2026 | 0.8x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | 0.1x | Very low |
| Q1 2025 | -1.0x | Net Cash |
| Q4 2024 | 0.8x | Very low |
EHTH's net debt is about 1.1 years of its operating earnings (EBITDA), up from less than a year a year ago. Net leverage isn't a meaningful measure for financial services companies like EHTH.
GS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.4x | Net Cash |
| Q2 2026 | -6.1x | Net Cash |
| Q1 2026 | -6.7x | Net Cash |
| Q4 2025 | -6.4x | Net Cash |
| Q3 2025 | -3.5x | Net Cash |
| Q2 2025 | -3.1x | Net Cash |
| Q1 2025 | -3.9x | Net Cash |
| Q4 2024 | -4.7x | Net Cash |
GS has the edge over EHTH on leverage, with a lower net debt burden relative to earnings.
EHTH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 22.2 | Oversold |
| Stochastic | 1.6 | Oversold |
EHTH's weekly RSI is 22 (oversold) and its Stochastic is 2 (oversold).
GS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.5 | Neutral |
| Stochastic | 16.3 | Oversold |
GS's weekly RSI is 45 (neutral) and its Stochastic is 16 (oversold).
EHTH PE vs Financial Services Sector
| Metric | EHTH | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
EHTH has no meaningful PE right now: it lost money over the past year.
GS PE vs Financial Services Sector
| Metric | GS | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 0.8% above |
| PE % | 46 | 63 | 17 pts below |
GS is trading at 13x earnings, in line with the Financial Services sector's median of 13x, though its earnings don't support one.
EHTH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.58 | 24% below |
| 20 week MA | $0.99 | 56% below |
| 50 week MA | $1.79 | 75% below |
| 100 week MA | $3.78 | 88% below |
| 200 week MA | $5.21 | 92% below |
EHTH is in a downtrend: it's below all five of its weekly moving averages, and 92% below its 200-week average.
GS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $895.5 | 2% above |
| 20 week MA | $977.4 | 6.5% below |
| 50 week MA | $945.4 | 3.4% below |
| 100 week MA | $804.5 | 14% above |
| 200 week MA | $602.7 | 52% above |
GS has the edge over EHTH on trend strength, trading above more of its moving averages.
EHTH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $94.4 | $73.9 | -22% |
| 2021 | $73.9 | $26.9 | -64% |
| 2022 | $26.9 | $4.43 | -84% |
| 2023 | $4.43 | $8.72 | +97% |
| 2024 | $8.72 | $8.65 | -0.8% |
| 2025 | $8.65 | $4.12 | -52% |
| 2026 YTD | $4.12 | $0.44 | -89% |
EHTH has finished lower in five of the last six years. It's down 89% so far in 2026.
GS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $230.7 | $256.2 | +11% |
| 2021 | $256.2 | $385.0 | +50% |
| 2022 | $385.0 | $345.5 | -10% |
| 2023 | $345.5 | $385.8 | +12% |
| 2024 | $385.8 | $576.2 | +49% |
| 2025 | $576.2 | $907.0 | +57% |
| 2026 YTD | $907.0 | $913.6 | +0.7% |
GS has the edge over EHTH on returns for 2026, with the stronger performance.